Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer

Programmed death ligand 1 (PD-L1) expression is a predictive biomarker of the success of PD-1/PD-L1 inhibitor therapy for patients with advanced non-small cell lung cancer (NSCLC) but its role as a prognostic marker for early stage resectable NSCLC remains unclear. Here, we studied PD-L1 expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Gen, Fan, Xirong, Zhu, Weifeng, Huang, Cheng, Zhuang, Wu, Xu, Haipeng, Lin, Xiandong, Hu, Dan, Huang, Yunjian, Jiang, Kan, Miao, Qian, Li, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663570/
https://www.ncbi.nlm.nih.gov/pubmed/29137398
http://dx.doi.org/10.18632/oncotarget.20233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663570/
https://www.ncbi.nlm.nih.gov/pubmed/29137398
http://dx.doi.org/10.18632/oncotarget.20233

Ejemplares similares